Dario Neri is Co-founder, CEO, CSO and President of the Scientific Advisory Board of Philogen. He graduated in Chemistry at the Scuola Normale Superiore in Pisa and obtained his PhD in Chemistry from the ETH Zürich, under the supervision of Prof. Kurt Wüthrich, winner of the Nobel Prize for Chemistry, 2002. For his dissertation, he was awarded the Silver Medal of ETH. After a 5 years post-doctoral research position in the lab of Sir Gregory Winter at the Cambridge Centre of Protein Engineering in Cambridge, UK, he returned to the ETH Zürich in 1996 as Assistant Professor in Molecular Structure Biology. Since 1999, he has been a Professor of Biomacromolecules in the department of Chemistry and Applied Biosciences at the ETH Zürich. He is the recipient of the ISOBM Abbott Prize 2000, of the Amgen-Dompe' Biotec Award 2000, of the Mangia d'Oro 2001, of the Prous Award 2006 of the European Federation of Medicinal Chemistry, of the Robert-Wenner-Prize 2007 of the Swiss Cancer League, of the SWISS BRIDGE Award 2008, of the Prix Mentzer 2011 of the French Medicinal Chemistry Society, of the Phoenix Prize 2014 and of an ERC Advanced Grant 2015. Prof. Neri is author of more than 300 publications in international journals.
Cornelia Halin Winter, born on 4th of October 1974 in Zurich, Switzerland, studied biochemistry at ETH Zurich (1993 – 1998). After obtaining her diploma, she spent 6 months working as an intern in the Department of Molecular Oncology at Genentech Inc., San Francisco, USA. From 1999 – 2002 she performed her PhD thesis in the laboratory of Prof. Dr. Dario Neri at the Institute of Pharmaceutical Sciences of ETH Zurich, working on immunocytokines and targeted tumor therapy. Her dissertation was awarded the ETH Zurich Silver Medal. From 2002 -2005, Cornelia Halin Winter performed a post-doc in the laboratory of Prof. Dr. Ulrich von Andrian at Harvard Medical School, Boston, USA, working in the field of leukocyte trafficking. In 2005 she returned to the Institute of Pharmaceutical Sciences of ETH Zurich to work as a post-doc and group leader in the laboratory of Prof. Dr. Michael Detmar in the field of lymphatic vessel biology. In June 2008 she received an appointment as Assistant Professor at ETH Zurich. At present, she holds the position of Associate Professor in the Institute of Pharmaceutical Sciences of ETH Zurich. Her research focuses on leukocyte migration and vascular biology in the context of inflammation and tumor growth. Since September 2011 Cornelia Halin Winter is a consultant for Philochem AG (Zurich, Switzerland) in the field of immunocytokines